OpenVSafe by OpenVAERS
Search V-safe

CVA-33471-59625

5 vaccinations 4 coded responses 26 check-ins 4 free-text entries 4 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
431 / OH
Registered
2021-01-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-16
    Registered in v-safe
  2. 2021-01-16
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-16
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness, Nausea, Diarrhea
    Adult check-in
  9. 2021-01-23
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-30
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-06
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  13. 2021-02-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  14. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  18. 2021-02-13
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  19. 2021-02-20
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-06
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-20
    Survey response — day 42, dose 2
    MedDRA: Dysphagia, Hypoaesthesia, Muscular weakness, Pre-existing disease, Unevaluable event, Visual impairment — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Increased weakness, numbness, of right hand. Decreased peripheral vision. Increased swallowing difficult. Have a HX of NMOSD - likely related to my medical condition · Healthcare visit (other): ST, MRI, EMG
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-03-20
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-05-08
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-07
    Survey response — 6 months, dose 2
    MedDRA: Dyspnoea, Pre-existing disease, Vocal cord dysfunction, Vocal cord paralysis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Vocal cord dysfunction, likely a dystonic reaction to an increase in dose of Modafinel I'm on for pathological fatigue related to NMOSD. Had an episode of inability to breathe due to temporary vocal cord paralysis.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  27. 2021-08-07
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-08-12
  29. 2021-08-13
  30. 2021-12-03
    Dose 3 — Pfizer-BioNTech
  31. 2022-02-06
    Survey response — 12 months, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Flare of NMOSD symptoms
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-02-06
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  33. 2022-02-07
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  34. 2022-02-07
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  35. 2022-02-07
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  36. 2022-04-29
    Dose 4 — Pfizer-BioNTech
  37. 2022-09-12
    Dose 5 — Moderna
    Co-administered: Flu:Tetanus
  38. 2022-10-10
    Survey response — day 28, dose 5
    MedDRA: Vocal cord dysfunction — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Worsening vocal cord dysfunction
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-10-10
    Report sent to call center — day 28, dose 5
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  40. 2022-10-11
  41. 2022-10-19
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  42. 2022-10-19
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  43. 2022-10-26
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-16Pfizer-BioNTech
22021-02-06Pfizer-BioNTech
32021-12-03Pfizer-BioNTech No
42022-04-29Pfizer-BioNTech No
52022-09-12Moderna Flu:Tetanus

Call center

4 call center cases

4 successful

See the call center timeline

Free text

Release 6 — day 42, dose 2

2021-03-20

Symptoms: Increased weakness, numbness, of right hand. Decreased peripheral vision. Increased swallowing difficult. Have a HX of NMOSD - likely related to my medical condition
Healthcare visit (other): ST, MRI, EMG

Release 9 — 6 months, dose 2

2021-08-07

Symptoms: Vocal cord dysfunction, likely a dystonic reaction to an increase in dose of Modafinel I'm on for pathological fatigue related to NMOSD. Had an episode of inability to breathe due to temporary vocal cord paralysis.

Release 11 — 12 months, dose 2

2022-02-06

Symptoms: Flare of NMOSD symptoms

Release 12 — day 28, dose 5

2022-10-10

Symptoms: Worsening vocal cord dysfunction

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDCondition aggravated · · ✓
SDDysphagia ✓ ✓ ✓
SDDyspnoea ✓ · ✓
SDHypoaesthesia ✓ ✓ ✓
SDMuscular weakness ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDVisual impairment ✓ ✓ ✓
SDVocal cord dysfunction ✓ · ✓
SDVocal cord paralysis ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release